Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Iridex Cp (IRIX)

5.58   -0.27 (-4.62%) 01-16 05:19
Open: 5.86 Pre. Close: 5.85
High: 5.8769 Low: 5.5
Volume: 74,521 Market Cap: 89M
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.883 - 5.922 5.922 - 5.955
Low: 5.427 - 5.464 5.464 - 5.495
Close: 5.525 - 5.586 5.586 - 5.636

Technical analysis

as of: 2022-01-15 8:47:28 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 7.23     One year: 7.80
Support: Support1: 5.40    Support2: 4.49
Resistance: Resistance1: 6.19    Resistance2: 6.68
Pivot: 5.96
Moving Average: MA(5): 5.75     MA(20): 5.93
MA(100): 7.07     MA(250): 7.00
MACD: MACD(12,26): -0.19     Signal(9): -0.20
Stochastic oscillator: %K(14,3): 44.24     %D(3): 40.76
RSI: RSI(14): 41.38
52-week: High: 9.71  Low: 4.45  Change(%): 3.5
Average Vol(K): 3-Month: 5525  10-Days: 3358

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
IRIX has closed above bottom band by 12.5%. Bollinger Bands are 26.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 16
Shares Float (M) 13
% Held by Insiders 27.83
% Held by Institutions 26.09
Shares Short (K) 169
Shares Short P. Month (K) 141

Stock Financials

EPS -0.200
EPS Est This Year -0.720
EPS Est Next Year -0.640
Book Value (p.s.) 1.600
Profit Margin -5.81
Operating Margin -10.67
Return on Assets (ttm) -8.6
Return on Equity (ttm) -13.9
Qtrly Rev. Growth 50.7
Gross Profit (p.s.) 0.980
Sales Per Share 3.210
EBITDA (p.s.) -0.304
Qtrly Earnings Growth
Operating Cash Flow (M) 10
Levered Free Cash Flow (M) 0

Stock Valuations

PE Ratio -27.90
PEG Ratio
Price to Book value 3.49
Price to Sales 1.74
Price to Cash Flow 9.08

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.